Search

Jay W Pettegrew

from Bradenton, FL
Age ~80
Get Report
Also known as:
Jay Wesley Pettegrew, Jay W Pettergrew, Jay W
Phone and address:
6424 Rookery Cir, Bradenton, FL 34203
(412) 362-6536
Related to:
Kimberly R Pettegrew, 38Donna Kesecker, 62Charles Welch, 38Angela Smith, 46Charles Welch, 63Charles J Welch, 52
Connected to:
Betty A Pettegrew, 72Helen H Pettegrew, 76Leonard A Pettek, 63Fabio Pettenati, 62Jocelyn R Pettenato, 39Kim M Petten, 61Robert H Petten, 41Charlotte A Pettengell, 80Christine H Pettengill, 49Ellen L Pettengell, 75

Jay Pettegrew Phones & Addresses

  • 6424 Rookery Cir, Bradenton, FL 34203 (412) 362-6536 (941) 752-2046
  • 3004 Fairmount Blvd, Cleveland, OH 44118 (216) 862-6696
  • 130 Desoto St, Pittsburgh, PA 15213 (412) 638-6082
  • 630 Linden Ave, Pittsburgh, PA 15208 (412) 362-6536
  • Dallas, TX

Work

Address: 3811 Ohara St, Pittsburgh, PA 15213 Specialities: Psychiatrist

Education

School / High School: University of Illinois At Chicago / College of Medicine 1969

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Neurology with Special Qualification in Child Neurology, 1977

Specialities

Pediatric Neurology

Professional Records

Medicine Doctors

Jay Pettegrew Photo 1

Dr. Jay W Pettegrew, Pittsburgh PA - MD (Doctor of Medicine)

View page
Specialties:
Pediatric Neurology
Address:
260 Kappa Dr, Pittsburgh, PA 15238

3811 Ohara St Suite 1237-E, Pittsburgh, PA 15213
(412) 624-1000 (Phone)
Certifications:
Neurology with Special Qualification in Child Neurology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Illinois At Chicago / College of Medicine
Graduated: 1969
Medical School
The Johns Hopkins Hospital
Graduated: 1969
Medical School
Barnes-Jewish Hospital
Graduated: 1969
Medical School
St Louis Chldns Hosp
Graduated: 1969
Jay Pettegrew Photo 2

Jay Wesley Pettegrew, Pittsburgh PA

View page
Specialties:
Neurology
Neurology with Special Qualifications in Child Neurology
Psychiatry
Work:
Western Psychiat
3811 Ohara St, Pittsburgh, PA 15261
University of Pittsburgh
130 Desoto St, Pittsburgh, PA 15213
Education:
University of Illinois at Chicago (1969)
Jay Pettegrew Photo 3

Jay Wesley Pettegrew, Pittsburgh PA

View page
Specialties:
Psychiatrist
Address:
3811 Ohara St, Pittsburgh, PA 15213
Education:
University of Illinois, College of Medicine - Doctor of Medicine
St. Louis Children's Hospital - Residency - Pediatric Neurology
Barnes-Jewish Hospital - Residency - Neurology
Johns Hopkins Hospital - Residency - Pediatrics
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology with Special Qualification in Child Neurology (Psychiatry and Neurology)

License Records

Jay Wesley Pettegrew

Address:
Pittsburgh, PA 15213
License #:
MD032305E - Expired
Category:
Medicine
Type:
Medical Physician and Surgeon

Business Records

Name / Title
Company / Classification
Phones & Addresses
Jay W. Pettegrew
Director
Upmc St. Margaret
Management Services
130 Desoto St, Pittsburgh, PA 15213
(412) 648-8541
Jay W. Pettegrew
Medical Doctor
Western Psychiatric Institute & Clinic
Medical Doctor's Office
3811 Ohara St, Pittsburgh, PA 15213
(412) 624-1000
Jay W. Pettegrew
President, Medical Doctor
Phfr, Inc
Holding Company · Nonclassifiable Establishments
235 Alpha Dr, Pittsburgh, PA 15238
3004 Fairmount Blvd, Cleveland, OH 44118
(412) 362-6536
Jay Wesley Pettegrew
Jay Pettegrew MD
Neurologist
3811 Ohara St, Pittsburgh, PA 15213
(412) 586-9421

Publications

Us Patents

Amyloid Binding Nitrogen-Linked Compounds For The Antemortem Diagnosis Of Alzheimers Disease, In Vivo Imaging And Prevention Of Amyloid Deposits

View page
US Patent:
6417178, Jul 9, 2002
Filed:
Nov 6, 1997
Appl. No.:
08/968902
Inventors:
William E. Klunk - Pittsburgh PA
Jay W. Pettegrew - Pittsburgh PA
Assignee:
University of Pittsburgh - Pittsburgh PA
International Classification:
C07C24510
US Classification:
514150, 51425211, 514258, 514308, 514314, 534550, 534557, 534670, 534677, 534653, 534816, 534822, 534823, 534827, 534828, 534829, 534830, 534831, 534832, 534833, 534834, 534835, 544 63, 544 64, 544 69, 544224, 544225, 544235, 546 2, 546 10, 546103, 546122, 546142, 548101, 548108, 548143, 548241, 548252, 548513, 556101, 562467, 562473, 562478
Abstract:
Amyloid binding compounds which are derivatives of Chrysamine G, pharmaceutical compositions containing, and methods using such compounds to identify Alzheimers brain in vivo and to diagnose other pathological conditions characterized by amyloidosis, such as Downs Syndrome are described. Pharmaceutical compositions containing Chrysamine G and derivatives thereof and methods using such compositions to prevent cell degeneration and amyloid-induced toxicity in amyloidosis associated conditions are also described. Methods using Chrysamine G derivatives to stain or detect amyloid deposits in biopsy or post-mortem tissue are also described. Methods using Chrysamine G derivatives to quantify amyloid deposits in homogenates of biopsy and post-mortem tissue are also described.

Compounds, Compositions And Methods For Treating Neuropsychiatric Disorders

View page
US Patent:
7407778, Aug 5, 2008
Filed:
Aug 5, 2005
Appl. No.:
11/198761
Inventors:
Jay W. Pettegrew - Pittsburgh PA, US
Samuel Gershon - Fox Chapel PA, US
Kanagasabai Panchalingam - Monroeville PA, US
International Classification:
C12P 21/04
A61K 35/78
A61K 31/225
A01B 79/00
A01N 37/30
US Classification:
435 701, 47 581, 4241951, 514548, 514556
Abstract:
Acetyl--carnitine (ALCAR) and L-carntine (LCAR) are nutraceuticals with indications in treating a variety of mental health disorders. A metabolomics-guided bioprocess method is presented to enhance LCAR and LCAR formation in germinating plant seeds. Metabolic fluxes are manipulated by germination in bioreactors to increase oxygen availability as well as provide an aseptic environment to alter carbohydrate consumption and feedback repress gluconeogenesis. Large shifts in sunflower seed fatty acid, phospholipid and high-energy metabolism change the germination environment and these metabolic changes lead to an approximate 1000-fold increase in natural LCAR and ALCAR production by the seeds. The resulting LCAR and ALCAR products from the seeds are used for treating mental health disorders including Alzheimer's disease, geriatric depression, non-geriatric depression and schizophrenia.

Compounds, Compositions And Methods For Producing Antioxidants From Carnitine

View page
US Patent:
7632662, Dec 15, 2009
Filed:
Jul 31, 2008
Appl. No.:
12/183609
Inventors:
Jay W. Pettegrew - Pittsburgh PA, US
Kanagasabai Panchalingam - Monroeville PA, US
Richard J. McClure - Pittsburgh PA, US
International Classification:
C12P 21/02
US Classification:
435 701, 514548, 514556
Abstract:
Carnitines are nutraceuticals with indications in treating a variety of mental health disorders. A metabolomics-guided bioprocess method is presented to produce longer chain fatty acid esters of carnitines such as polyunsaturated fatty acid esters including eicosapentaenoyl-L-carnitine and/or docosahexaenyl-L-carnitine in germinating plant seeds. The resulting products from the plant seeds are used as a natural nutritional source of powerful human antioxidants.

Method And System For Diagnosis Of Neuropsychiatric Disorders Including Chronic Alcoholism

View page
US Patent:
7700074, Apr 20, 2010
Filed:
Aug 23, 2005
Appl. No.:
11/209318
Inventors:
Jay W. Pettegrew - Pittsburgh PA, US
Kanagasabai Panchalingam - Monroeville PA, US
International Classification:
A61K 49/00
A61B 5/055
A61K 31/70
A61K 31/66
A61K 31/22
A61K 31/205
US Classification:
424 91, 424 93, 514 44, 514 75, 514546, 514556
Abstract:
Chronic alcoholism is a diverse and heterogeneous disorder that can be dichotomized into cognitively intact and cognitively impaired subgroups. At a molecular level, ethanol has been shown to have both acute and chronic effects on: Membrane biophysical properties, Membrane composition and metabolism, Protein phosphorylation, Lipid metabolic signaling, Lipoprotein transport of cholesterol. Actual molecular underpinnings are determined for cognitive impairment seen in some chronic alcoholism subjects including molecular/metabolic alterations of phospholipid and ganglioside metabolisms.

Compounds, Compositions And Methods For Medical Imaging Of Neuropsychiatric Disorders

View page
US Patent:
7815894, Oct 19, 2010
Filed:
May 27, 2004
Appl. No.:
10/854894
Inventors:
Jay W. Pettegrew - Pittsburgh PA, US
Richard J. McClure - Pittsburgh PA, US
Kanagasabai Panchalingam - Monroeville PA, US
Billy W. Day - Pittsburgh PA, US
International Classification:
A61K 51/00
A61M 36/14
US Classification:
424 177, 424 111, 424 165, 424 181, 424 185, 424 189, 424 91, 424 92, 424 93, 424 94
Abstract:
Compounds, compositions and methods for the diagnosis of Alzheimer's disease. Synthesized Glycerophosphocholine (GPC) may be used as a diagnostic aid to measure progression of Alzheimer's disease. GPC is a membrane phospholipid metabolite that is capable of binding specifically to the β-turn of beta amyloid (Aβ) peptide. Compounds including non-radioactive, paramagnetic, and radioactive derivatives of GPC are presented. These compounds possess similar binding properties to original GPC molecules and are useful in medical magnetic resonance imaging and/or positron emission tomography applications. By employing these radiological techniques in conjunction with the compositions of the present invention, the diagnosis and assessment of the progression of Alzheimer's disease may be achieved.

Compounds, Compositions And Methods For Medical Imaging Of Parkinson's Disease

View page
US Patent:
8329142, Dec 11, 2012
Filed:
Jul 23, 2008
Appl. No.:
12/178281
Inventors:
Jay W. Pettegrew - Pittsburgh PA, US
Richard J. McClure - Pittsburgh PA, US
Kanagasabai Panchalingam - Monroeville PA, US
International Classification:
A61K 51/00
A61M 36/14
US Classification:
424 189, 424 111, 424 165, 424 181, 424 185, 424 91
Abstract:
Compounds, compositions and methods for the detection and diagnosis of Parkinson's disease. Derivative lycerophosphocholine (GPC) compounds are used as a detection and diagnostic aid to measure progression of Parkinson's disease by detecting GPC binding to α-synuclein. Derivative CPG compounds including non-radioactive, paramagnetic, and radioactive derivatives of GPC are presented. These compounds possess similar binding properties to original GPC molecules and are useful in medical magnetic resonance imaging (MRI) and/or positron emission tomography (PET) applications. By employing these radiological techniques in conjunction with the compositions of the present invention, the detection, diagnosis and assessment of the progression of Parkinson's disease may be achieved.

Carnitine In The Treatment Of Depression

View page
US Patent:
20040009926, Jan 15, 2004
Filed:
Feb 7, 2003
Appl. No.:
10/359560
Inventors:
Jay Pettegrew - Pittsburgh PA, US
Samuel Gershon - Fox Chapel PA, US
Assignee:
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
International Classification:
A61K031/7024
A61K031/22
A61K031/66
US Classification:
514/023000, 514/550000, 514/129000
Abstract:
Geriatric depression is treated with L-carnitine or an alkanoyl L-carnitine, desirably acetyl L-carnitine thereby avoiding unwanted side-effects exhibited by conventional antidepressant agents.

Methor For Use Of Acetyl-L-Carnitine (Alcar) For Treatment Of Depressive Disorders In Humans

View page
US Patent:
20050272812, Dec 8, 2005
Filed:
Apr 27, 2005
Appl. No.:
11/117126
Inventors:
Jay Pettegrew - Pittsburgh PA, US
Samuel Gershon - Fox Chapel PA, US
International Classification:
A61K031/22
US Classification:
514546000
Abstract:
Depression and bi-polar depression are treated with an acetyl-L-carnitine (ALCAR), thereby avoiding unwanted side-effects exhibited by conventional antidepressant agents. ALCAR also helps prevents recurrent episodes of depression and bi-polar depression and both provides beneficial membrane phospholipid and high-energy phosphate changes in a brain of human subjects with major depressive disorders (MDD).
Control profile
Jay W Pettegrew from Bradenton, FL, age ~80 Get Report